“If you’ve treated a low and your numbers are coming back up, why does your brain still feel off for hours?”
HIGHLIGHTS
- When blood glucose levels drop, the brain is deprived of energy, which can cause symptoms such as confusion and difficulty concentrating.
- Even after blood sugar recovers, the brain’s ability to turn glucose into energy can lag behind, which is why brain fog often lasts longer.
- The brain is metabolically flexible and can use natural adaptive energy sources to support the brain when glucose metabolism is impaired.
- New solutions combine fast-acting carbs with these adaptive fuels to support a faster, complete recovery from hypos.
Hypoglycaemia, or a ‘hypo’ (low blood sugar), is a common and often stressful experience for people managing diabetes. The immediate symptoms like shaking, sweating, and confusion are widely recognized, but for many, the struggle doesn’t end once blood sugar is back in range.
Instead, a lingering ‘hypo hangover’ can kick in, bringing hours of brain fog, fatigue and a sense of being ‘not quite yourself’. So why does it take so long to feel normal again after treating a low? The answer lies in the way your brain manages energy under stress and how quickly it can clear the backlog in its energy systems.
GLUCOSE: THE BRAIN’S PRIMARY FUEL
Your brain is only about 2% of your body weight, but it uses roughly 20% of your total energy, even while you sleep. Under normal conditions, it relies almost entirely on glucose (sugar) from your bloodstream, which is transported across the blood–brain barrier to fuel brain cells.
Inside brain cells, glucose is converted into usable energy through a multi‑step pathway called glycolysis. In this process, glucose is broken down into smaller molecules, generating ATP, the cell’s main energy currency. This process is supported by “helper molecules” such as NAD⁺ that keep the reactions running smoothly. Under stable glucose conditions, glycolysis runs continuously, supplying a reliable flow of ATP to support normal brain activity and maintain clear thinking and alertness (Figure 1A).
Because brain cells cannot store much energy, they depend on a steady supply of glucose to support thinking, movement, and essential survival functions. When that supply is disrupted, the impact is felt quickly in how you feel and think.
WHAT HAPPENS INSIDE YOUR BRAIN DURING A HYPO?
Stage 1: Fuel supply drops
When blood glucose falls, the brain’s main fuel source is suddenly limited, triggering the early neuroglycopenic symptoms of a hypo such as confusion, dizziness, and difficulty concentrating.
Stage 2: Hypoglycaemia triggers cellular stress
A hypo is not just a fuel shortage – it is a metabolic stress event for brain cells.
Low glucose triggers cellular stress and the production of reactive oxygen species (ROS). To protect itself, the cell activates emergency repair systems, including an enzyme called PARP-1.
PARP-1 helps repair cellular damage, but it comes at a cost.
Stage 3: NAD⁺ depletion creates an energy bottleneck
Once activated, PARP-1 rapidly consumes NAD⁺, a molecule that is essential for glucose metabolism.
NAD⁺ is required for a key step in glycolysis, carried out by the enzyme GAPDH. When NAD⁺ levels fall, this step becomes blocked.
As a result:
- Glucose can still enter the brain cells
- But it cannot move efficiently through glycolysis
- ATP (the cell’s energy currency) production drops sharply
This is the glycolytic bottleneck (Figure 1B).
Stage 4: Why recovery takes longer than expected
When blood glucose levels rise again, the problem is not immediately solved.
Although glucose is now available, glycolysis remains constrained until NAD⁺ levels are replenished, which can take time.
During this recovery window:
- ATP production remains suboptimal
- Some glucose is diverted into stress-related pathways rather than energy generation
- Brain energy levels lag behind blood glucose readings
This mismatch between “normal” glucose numbers and low brain energy is what drives the hypo hangover – lingering brain fog, fatigue, and slowed thinking after the low appears to be treated. This recovery gap explains why restoring blood sugar alone does not always restore how the brain feels or functions – and why adaptive energy pathways matter.
ADAPTIVE ENERGY IN THE BRAIN
Fortunately, the brain is adaptable. When glucose is low and glycolysis is impaired, it can use natural “adaptive energy” sources instead – particularly β‑hydroxybutyrate (BHB) and lactate – to help maintain energy supply.
The key advantage of these fuels, as shown in Figure 1C, is that they enter the mitochondria (the cell’s powerhouses) through different transporters and pathways than glucose. This allows them to bypass the glucose‑related bottleneck and support ATP production during and after a hypo.
Beyond just providing quick energy, BHB and lactate have additional protective effects; they can neutralize harmful molecules in the brain, which helps reduce the temporary cellular stress.
![]()
Figure 1. Brain energy dynamics during hypoglycaemia and adaptive energy support.
(A) Under normal conditions, the brain efficiently converts glucose into energy (ATP) through its usual energy-making pathway.
(B) During hypoglycaemia, metabolic stress activates cellular repair pathways (including PARP-1), which deplete NAD⁺ and block the GAPDH step of glycolysis. This creates a metabolic bottleneck, reducing ATP production and increasing cellular stress even after glucose returns.
(C) Adaptive energy sources such as β-hydroxybutyrate (BHB) and lactate bypass the bottleneck by entering mitochondrial energy pathways directly. This helps restore ATP levels and reduce cellular stress during recovery, even while glucose processing remains impaired.
Understanding this brain energy bottleneck has shifted how researchers think about hypo recovery. Instead of focusing only on raising blood sugar, newer approaches aim to support brain energy during the recovery window – the period after a low when glucose is present, but not yet fully usable.
THE KLARIO DIFFERENCE
Recovering from a hypo is not just about bringing your blood sugar back into range on a glucose meter; it is about restoring energy to the brain during the critical recovery window that follows.
Klario was developed specifically to address this gap. It applies the science of adaptive energy by combining fast-acting carbohydrates with β-hydroxybutyrate (BHB) and lactate – fuels that can bypass the energy bottleneck and support brain energy even while glucose metabolism is still recovering.
In a clinical evaluation of Klario, supplying these adaptive energy sources alongside glucose during a hypo was more effective than standard sugar alone. Key findings included:
- Faster Recovery: 75% returned to daily activities sooner.
- Quicker symptom relief: 73% experienced faster resolution of hypo symptoms
- Greater confidence: 82% felt more in control with managing their hypos
- Better Stability: 27% reduction in the risk of a "rebound" or recurrent hypo.
Backed by two independent clinical studies and tested in over 1,000 hypoglycaemic events, Klario represents a next-generation approach to hypo recovery – one designed to support a faster, complete recovery.
Want to explore the details? Read more about the science behind Klario and the clinical data supporting adaptive energy in hypo recovery here.
Disclaimer: Klario is a functional food for the management of hypoglycaemia. It is not intended to replace medical advice. Always consult your healthcare provider for guidance on your diabetes management.
GLOSSARY
Glycolysis - The process cells use to turn glucose into energy (ATP). During and after a hypo, this pathway can temporarily slow or stall.
ATP (Adenosine Triphosphate) - The cell’s main energy source. Low ATP in the brain contributes to fatigue, brain fog, and slowed thinking.
NAD⁺ - A helper molecule required for glycolysis to work. During hypoglycaemia, NAD⁺ can be depleted, limiting the brain’s ability to use glucose for energy.
PARP-1 - An enzyme involved in cellular repair. When activated during metabolic stress, it consumes NAD⁺, which can unintentionally reduce energy production.
GAPDH - A key enzyme in glycolysis that depends on NAD⁺. When NAD⁺ is low, this step becomes blocked, creating an energy bottleneck.
Neuroglycopenic symptoms - Brain-related symptoms caused by low glucose, such as confusion, dizziness, difficulty concentrating, and slowed thinking.
Hypoglycaemia (Hypo) - Low blood glucose. Clinically defined as below 3.9 mmol/L (70 mg/dL), but often experienced as both physical and cognitive symptoms.
Mitochondria - The “powerhouses” of the cell where most energy (ATP) is produced.
β-Hydroxybutyrate (BHB) - A natural adaptive energy source the brain can use when glucose metabolism is impaired.
Lactate - A naturally occurring fuel that the brain can use to support energy production, especially when glucose processing is disrupted.
Adaptive energy - Natural fuels (such as BHB and lactate) that help the brain maintain energy when glucose use is limited.
REFERENCES
Cryer PE et al. Hypoglycemia in Diabetes. Diabetes Care. 2003 Jun 1;26(6):1902–12.
Ceriello A et al. Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes. Diabetes. 2012
Zammitt NN et al. Delayed Recovery of Cognitive Function Following Hypoglycemia in Adults With Type 1 Diabetes. Diabetes. 2008 Mar 1;57(3):732–6.
Jensen NJ et al. Effects of β-hydroxybutyrate on cognition in patients with type 2 diabetes. Eur J Endocrinol. 2020 Feb;182(2):233–42.